Cargando…

The Lipid Profile and Mortality Risk in Elderly Type 2 Diabetic Patients: A Ten-Year Follow-Up Study (ZODIAC-13)

BACKGROUND: The precise relationship between the lipid profile and mortality in elderly patients with type 2 diabetes mellitus (T2DM) remains unclear. The aim of this study was to investigate the relationship between the lipid profile over time, and mortality in elderly patients with T2DM. METHODS A...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Hateren, Kornelis J. J., Landman, Gijs W. D., Kleefstra, Nanne, Logtenberg, Susan J. J., Groenier, Klaas H., Kamper, Adriaan M., Houweling, Sebastiaan T., Bilo, Henk J. G.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795197/ https://www.ncbi.nlm.nih.gov/pubmed/20041116 http://dx.doi.org/10.1371/journal.pone.0008464

Ejemplares similares

Health-Related Quality of Life and Mortality in a General and Elderly Population of Patients With Type 2 Diabetes (ZODIAC-18)
por: Landman, Gijs W.D., et al.
Publicado: (2010)

Sex Differences in the Quality of Diabetes Care in the Netherlands (ZODIAC-45)
por: Hendriks, Steven H., et al.
Publicado: (2015)

Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
por: Landman, Gijs W.D., et al.
Publicado: (2010)

Addition of sulphonylurea to metformin does not relevantly change body weight: a prospective observational cohort study (ZODIAC‐39)
por: Schrijnders, Dennis, et al.
Publicado: (2016)

A prospective observational study of quality of diabetes care in a shared care setting: trends and age differences (ZODIAC-19)
por: van Hateren, Kornelis J J, et al.
Publicado: (2012)

Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol
por: Schrijnders, Dennis, et al.
Publicado: (2017)

Sex differences in survival of patients with type 2 diabetes in primary care (ZODIAC-50)
por: Hendriks, Steven H, et al.
Publicado: (2017)

The Midregional Fragment of Pro-A–Type Natriuretic Peptide, Blood Pressure, and Mortality in a Prospective Cohort Study of Patients With Type 2 Diabetes (ZODIAC-25)
por: van Hateren, Kornelis J.J., et al.
Publicado: (2013)

Within-Sulfonylurea-Class Evaluation of Time to Intensification with Insulin (ZODIAC-43)
por: Schrijnders, Dennis, et al.
Publicado: (2016)

Gender differences in the evaluation of care for patients with type 2 diabetes: a cross-sectional study (ZODIAC-52)
por: Hendriks, Steven H., et al.
Publicado: (2018)

Serum Proenkephalin A Levels and Mortality After Long-Term Follow-Up in Patients with Type 2 Diabetes Mellitus (ZODIAC-32)
por: van Hateren, Kornelis J. J., et al.
Publicado: (2015)

Serum Peroxiredoxin 4: A Marker of Oxidative Stress Associated with Mortality in Type 2 Diabetes (ZODIAC-28)
por: Gerrits, Esther G., et al.
Publicado: (2014)

Association between 9p21 genetic variants and mortality risk in a prospective cohort of patients with type 2 diabetes (ZODIAC-15)
por: Landman, Gijs WD, et al.
Publicado: (2012)

Demographical, Clinical, and Psychological Characteristics of Users and Nonusers of an Online Platform for T2DM Patients (e-VitaDM-3/ZODIAC-44)
por: Roelofsen, Yvonne, et al.
Publicado: (2016)

Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: a cohort study (ZODIAC-56)
por: Hendriks, Steven H, et al.
Publicado: (2018)

Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes: A randomized controlled trial
por: Logtenberg, Susan J., et al.
Publicado: (2010)

Lifestyle and emotional well-being in men and women with type 2 diabetes (e-VitaDM-4; ZODIAC-48)
por: Hendriks, Steven H., et al.
Publicado: (2017)

Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31)
por: Riphagen, Ineke J., et al.
Publicado: (2013)

Comparison of Methods for Renal Risk Prediction in Patients with Type 2 Diabetes (ZODIAC-36)
por: Riphagen, Ineke J., et al.
Publicado: (2015)

Plasma COOH-Terminal Proendothelin-1: A marker of fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in type 2 diabetes? (ZODIAC-29)
por: Drion, Iefke, et al.
Publicado: (2012)

The relationship between N-terminal prosomatostatin, all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus (ZODIAC-35)
por: van Dijk, Peter R, et al.
Publicado: (2015)

Safety and Efficacy of Gliclazide as Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Trials
por: Landman, Gijs W. D., et al.
Publicado: (2014)

Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
por: Kleefstra, Nanne, et al.
Publicado: (2009)

Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: A randomized controlled trial
por: Logtenberg, Susan J., et al.
Publicado: (2009)

Self-Monitoring of Blood Glucose: The Use of the First or the Second Drop of Blood
por: Hortensius, Johanna, et al.
Publicado: (2011)

Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40)
por: Roelofsen, Yvonne, et al.
Publicado: (2014)

Effects of three frequencies of self-monitored blood glucose on HbA1c and quality of life in patients with type 2 diabetes with once daily insulin and stable control: a randomized trial
por: Hortensius, Johanna, et al.
Publicado: (2018)

Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49)
por: Schrijnders, Dennis, et al.
Publicado: (2018)

Laser therapy for onychomycosis in patients with diabetes at risk for foot complications: study protocol for a randomized, double-blind, controlled trial (LASER-1)
por: Nijenhuis-Rosien, Leonie, et al.
Publicado: (2015)

Patient Activation in Type 2 Diabetes: Does It Differ between Men and Women?
por: Hendriks, Steven H., et al.
Publicado: (2016)

Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up
por: van Dijk, Peter R, et al.
Publicado: (2014)

Route of Insulin Does Not Influence 25-Hydroxyvitamin D Concentrations in Type 1 Diabetes: A Brief Report
por: van Dijk, Peter R, et al.
Publicado: (2019)

Validation of the howRu and howRwe questionnaires at the individual patient level
por: Hendriks, Steven H., et al.
Publicado: (2015)

Comment on: Bosi et al. Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. Diabetes Care 2013;36:2887–2894
por: Kleefstra, Nanne, et al.
Publicado: (2013)

Different routes of insulin administration do not influence serum free thiols in type 1 diabetes mellitus
por: van Dijk, Peter R., et al.
Publicado: (2019)

Life Expectancy in a Large Cohort of Type 2 Diabetes Patients Treated in Primary Care (ZODIAC-10)
por: Lutgers, Helen L., et al.
Publicado: (2009)

Clinical evaluation of analytical variations in serum creatinine measurements: why laboratories should abandon Jaffe techniques
por: Drion, Iefke, et al.
Publicado: (2012)

Type 2 diabetes seems not to be a risk factor for the carpal tunnel syndrome: a case control study
por: Hendriks, Steven H, et al.
Publicado: (2014)

Effect of i.p. insulin administration on IGF1 and IGFBP1 in type 1 diabetes
por: van Dijk, P R, et al.
Publicado: (2014)

The Value of Glycemic Control Prior to Cancer Diagnosis on All-Cause Mortality among Patients with Type 2 Diabetes in Dutch Primary Care
por: de Haan-Du, Jing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rhtc4br0peptcnr7sauhqimf8o